According to Eric Topol, the chief academic officer at Scripps Health, use of statins could be responsible for over 100,000 cases of induced diabetes in the US alone. The FDA considers this a small risk. This makes me wonder how many people constitute a large risk. See his full essay in the NY Times.
Ambien CR Zolpiderm nausea hallucinations Ambien heart disease Jacob Teitelbaum M.D. Oscar H. Franco MD PhD European Society of Cardiology Congress 2011 binge eating constipation celexa prozac weight gain lexapro ssri disorientation suicidal thinking impair alertness and coordination chocolate profit Scripps Health Beatrice A. Golomb Eric Topol UCSD Statin Effects Study reporting side effects memory loss pharmaceutical companies FDA cognitive impairment depression anxiety statins. memory loss muscle pain diabetes cholesterol Crestor Zocor Lipitor statins fogginess